Cargando…

1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak

Detalles Bibliográficos
Autores principales: Pastorino, A., Negru, M.E., Vigani, A., Vaira, F., Tognoni, A., Ferrari, A., Ricci, I., Rondini, M., Olcese, F., Milano, A., Cozzani, F., Aschele, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506391/
http://dx.doi.org/10.1016/j.annonc.2020.08.1789
_version_ 1783585007754805248
author Pastorino, A.
Negru, M.E.
Vigani, A.
Vaira, F.
Tognoni, A.
Ferrari, A.
Ricci, I.
Rondini, M.
Olcese, F.
Milano, A.
Cozzani, F.
Aschele, C.
author_facet Pastorino, A.
Negru, M.E.
Vigani, A.
Vaira, F.
Tognoni, A.
Ferrari, A.
Ricci, I.
Rondini, M.
Olcese, F.
Milano, A.
Cozzani, F.
Aschele, C.
author_sort Pastorino, A.
collection PubMed
description
format Online
Article
Text
id pubmed-7506391
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75063912020-09-23 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak Pastorino, A. Negru, M.E. Vigani, A. Vaira, F. Tognoni, A. Ferrari, A. Ricci, I. Rondini, M. Olcese, F. Milano, A. Cozzani, F. Aschele, C. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506391/ http://dx.doi.org/10.1016/j.annonc.2020.08.1789 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pastorino, A.
Negru, M.E.
Vigani, A.
Vaira, F.
Tognoni, A.
Ferrari, A.
Ricci, I.
Rondini, M.
Olcese, F.
Milano, A.
Cozzani, F.
Aschele, C.
1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak
title 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak
title_full 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak
title_fullStr 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak
title_full_unstemmed 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak
title_short 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak
title_sort 1725p development and validation of telematic follow-up for cancer patients during the covid-19 outbreak
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506391/
http://dx.doi.org/10.1016/j.annonc.2020.08.1789
work_keys_str_mv AT pastorinoa 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT negrume 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT vigania 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT vairaf 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT tognonia 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT ferraria 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT riccii 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT rondinim 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT olcesef 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT milanoa 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT cozzanif 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak
AT aschelec 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak